Login
Toggle sidebar

Lint: hereditary-spherocytosis

hereditary-spherocytosis
Emphasis
warning

"ankyrin (ANK1)"

Line 23:17 · Italics should be used only in exceptional circumstances: '<em>ANK1</em>'

"band 3 (SLC4A1)"

Line 24:16 · Italics should be used only in exceptional circumstances: '<em>SLC4A1</em>'

"α spectrin (SPTA1)"

Line 25:20 · Italics should be used only in exceptional circumstances: '<em>SPTA1</em>'

"β spectrin (SPTB)"

Line 26:20 · Italics should be used only in exceptional circumstances: '<em>SPTB</em>'

"protein 4.2 (EPB42)"

Line 27:21 · Italics should be used only in exceptional circumstances: '<em>EPB42</em>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Complications"

Line 32:1 · "Complications" is under the wrong parent heading (found under "Treatment and prognosis").
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0